Compare RAYMED LABS. with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RAYMED LABS vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    RAYMED LABS AUROBINDO PHARMA RAYMED LABS/
AUROBINDO PHARMA
 
P/E (TTM) x -5.4 7.5 - View Chart
P/BV x - 1.8 - View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 RAYMED LABS   AUROBINDO PHARMA
EQUITY SHARE DATA
    RAYMED LABS
Mar-20
AUROBINDO PHARMA
Mar-21
RAYMED LABS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs31,023 0.3%   
Low Rs1333 0.3%   
Sales per share (Unadj.) Rs0422.8 0.0%  
Earnings per share (Unadj.) Rs-0.192.0 -0.1%  
Cash flow per share (Unadj.) Rs-0.1110.0 -0.1%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs-4.6374.3 -1.2%  
Shares outstanding (eoy) m4.27585.94 0.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio xNM1.6-  
Avg P/E ratio x-14.87.4 -200.6%  
P/CF ratio (eoy) x-16.66.2 -268.8%  
Price / Book Value ratio x-0.41.8 -22.9%  
Dividend payout %04.3 0.0%   
Avg Mkt Cap Rs m8397,398 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m035,350 0.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m0247,746 0.0%  
Other income Rs m03,809 0.0%   
Total revenues Rs m0251,555 0.0%   
Gross profit Rs m-181,480 -0.0%  
Depreciation Rs m010,554 0.0%   
Interest Rs m0745 0.0%   
Profit before tax Rs m-173,990 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m020,098 0.0%   
Profit after tax Rs m-153,892 -0.0%  
Gross profit margin %NM32.9- 
Effective tax rate %027.2 0.0%   
Net profit margin %NM21.8- 
BALANCE SHEET DATA
Current assets Rs m1198,235 0.0%   
Current liabilities Rs m22106,652 0.0%   
Net working cap to sales %NM37.0- 
Current ratio x01.9 2.2%  
Inventory Days DaysNM19- 
Debtors Days DaysNM52- 
Net fixed assets Rs m2135,778 0.0%   
Share capital Rs m43586 7.3%   
"Free" reserves Rs m-63218,713 -0.0%   
Net worth Rs m-20219,299 -0.0%   
Long term debt Rs m01,684 0.0%   
Total assets Rs m3334,013 0.0%  
Interest coverage xNM100.3-  
Debt to equity ratio x00 0.0%  
Sales to assets ratio x00.7 0.0%   
Return on assets %-21.716.4 -132.4%  
Return on equity %2.824.6 11.4%  
Return on capital %2.833.8 8.3%  
Exports to sales %NM53.8-  
Imports to sales %NM16.4-  
Exports (fob) Rs mNA133,248 0.0%   
Imports (cif) Rs mNA40,615 0.0%   
Fx inflow Rs m0133,248 0.0%   
Fx outflow Rs m044,946 0.0%   
Net fx Rs m088,302 0.0%   
CASH FLOW
From Operations Rs m033,289 0.0%  
From Investments Rs mNA5,987 0.0%  
From Financial Activity Rs mNA-13,648 0.0%  
Net Cashflow Rs m025,831 0.0%  

Share Holding

Indian Promoters % 28.4 48.8 58.2%  
Foreign collaborators % 0.0 3.1 -  
Indian inst/Mut Fund % 1.0 37.2 2.6%  
FIIs % 0.0 21.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 71.6 48.2 148.7%  
Shareholders   1,428 329,940 0.4%  
Pledged promoter(s) holding % 0.0 24.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare RAYMED LABS With:   NORRIS MEDICINES  LINCOLN PHAR  FREDUN PHARMA  ISTREET NETWORK  LAURUS LABS   



Today's Market

5 Reasons Why Sensex Plunged 765 Points Today(Closing)

It was a volatile day for Indian share market today. After opening the day in green, benchmark indices erased gains within the first hour and kept falling as the session progressed.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

Aurobindo Pharma's Stock Falls After Profits Decline 7% (Views On News)

Jun 1, 2021

Aurobindo Pharma shares fell nearly 4% after quarterly earnings disappoint.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

RAYMED LABS SHARE PRICE


Nov 29, 2021 (Close)

TRACK RAYMED LABS

  • Track your investment in RAYMED LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

RAYMED LABS 5-YR ANALYSIS

COMPARE RAYMED LABS WITH

MARKET STATS